In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

444 News Items found
Dr. Larry Norton
Teaching Machines To Recognize Cancer

MSK's Dr. Larry Norton, a national breast cancer expert, discusses how artificial intelligence is helping doctors.
In the News
A presentation stage at the San Antonio Breast Cancer Symposium.
Updates from SABCS 2019: Detection and Screening, Immunotherapy Advances, and Therapy Resistance

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.
Honors
Charles Sawyers, Kenneth Offit, and Larry Norton
Three Memorial-Sloan Kettering Researchers Receive Special Awards by the American Society of Clinical Oncology

Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.
Actionable Insight to Raise Breast Health Awareness

Women want to understand and decrease their risk of breast cancer, and Nicole Saphier, MD, Director of Breast Imaging at MSK Monmouth, wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness Month, and every day.
Drs. Danielle Rochlin and Babek Mehrara
MSK Research Aims to Better Predict and Prevent Lymphedema After Breast Cancer Surgery

Doctors and nurses with Memorial Sloan Kettering’s Plastic and Reconstructive Surgical Service have developed new, simplified models to better predict and prevent breast cancer-related lymphedema.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
Feature
Joanna Ihlo
Fighting Cancer on a Fixed Income: How MSK Helps Patients Cope With Financial Uncertainty

Learn how MSK helps patients navigate the intricacies of insurance and financial assistance throughout their cancer treatment.
In the Lab
A section of breast tissue with cancerous changes identified.
A Deeper Vision: How Digital Technology Is Aiding Breast Cancer Diagnosis

By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.
Finding
MSK investigators Michael Berger and David Solit.
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.